UCI Health, the clinical enterprise of the University of California, Irvine, has opened the world's first in-human embryonic stem cell-derived clinical trial for Huntington's disease.

Could cord tissue stem cells change how we treat chronic pain and disease?

Scientists restored stroke-damaged brain tissue in mice, raising hopes that recovery may begin long after a stroke.

An international team of experts in embryology and bioethics has published the first white paper on the use of embryonic ...

A man and a woman with a rare and devastating autoimmune disease have been in remission for more than 15 years after ...

Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...

Megan covers the intersection of science and society. How is biomedical research funded? Who benefits? And how do new technologies reflect and shape our values? You can reach Megan on Signal at ...

New scientific methods could one day render animal studies—the standard in research laboratories for more than 100 years—obsolete. Clive Svendsen, Ph.D., executive director of the Board of Governors ...

Anti-T-lymphocyte globulin (ATLG) for the prevention of graft-versus-host disease (GvHD) reduces complications and ...

Dental tissues development involves two distinct cell lineages: mesenchymal cells (derived from the cranial neural crest) and epithelial cells (derived from oral ectoderm and pharyngeal epithelium).

Stem cells made a public splash with large research breakthroughs in the 90s and early 2000s. However, since then, stem cells have largely been adopted by the alternative medicine and wellness world ...

If you are a parent of a young child with autism (especially level 2 or 3, requiring significant support), the promise of a ...